Miso Clinic · Clinical Reference

CellREDM: the same hADM idea, ground finer

CellREDM belongs to the same class as Re2O. The premise is identical — take donated human skin, strip out the cells, and put the remaining structural material back into a dermis that has lost its own. What differs is particle size, and that difference decides where the product can go. This page covers what it is, how we choose between the two hADM products, and where it stops being the right answer.

Clinical reference About an 8-minute read Reviewed 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak 한국어판

In one paragraph

CellREDM is an injectable skin booster made in South Korea by Hans Biomed. Its active material is hADM — human acellular dermal matrix. Donated human skin is processed to remove all cells and DNA, and the remaining extracellular matrix — collagen, elastin, glycosaminoglycans — is milled to roughly 75-micrometre particles and injected into the dermis. It replaces material the skin has lost rather than signalling the skin to make more.

At a glance

CellREDM
CategoryInjectable skin booster (human tissue–derived)
Active materialhADM — human acellular dermal matrix
Particle sizeApproximately 75 μm
Principal componentsCollagen, elastin, glycosaminoglycans
SourceDonated human skin, processed to remove all cells and DNA
ManufacturerHans Biomed, South Korea (Korean distribution by Hugel)
DeliveryFine-needle multi-point injection into the dermis
AppointmentAbout 30–40 minutes including topical anaesthetic
TargetsDermal density, texture, hydration — particularly in thin skin
Does not treatVolume loss, contour laxity, deep dynamic wrinkles

What smaller particles actually change

In this class, particle size is not a specification detail. It determines where the product can be used at all.

Resistance on injection rises with particle size, and two consequences follow. First, more force is needed and the treatment hurts more. Second, product tends to collect rather than distribute. Neither matters much in thick skin. In periorbital skin, both show.

CellREDM addresses this by milling the matrix to approximately 75 μm. Lower injection resistance and less clumping make thin, reactive areas more approachable.

On numbers — The 75 μm figure comes from the manufacturer. Other figures for concentration and volume circulate online; we could not verify them against manufacturer documentation, so they are deliberately absent here. We will show you the labelling of the product actually used at your consultation.

What hADM is — starting with the source

The raw material deserves stating plainly: CellREDM begins with donated human skin. A good deal of promotional material avoids saying so. We would rather you knew and chose.

What is injected is not skin. Donated tissue undergoes decellularisation — detergents, enzymes, repeated freeze-thaw — which removes cells, cellular debris, and the cell-surface antigens and DNA that would otherwise provoke an immune response. What remains is the scaffold: collagen types I and III, elastin, and the glycosaminoglycans that bind water.

This material was not invented for aesthetics. It has a long history in severe burn reconstruction and breast reconstruction, where a surgeon needs a scaffold the body can build into. Products like CellREDM take that same material, reduce it to fine particles, and make it injectable.

Our Re2O reference covers the composition and processing of hADM at greater length.

How we choose between CellREDM and Re2O

Miso Clinic stocks both hADM products. They share a goal, so the choice comes down to site and skin thickness.

Being straightforward about it: no study has compared the two products directly. There is no basis for calling either superior. We stock both because a clinic holding one product ends up using that product everywhere.

The two hADM products
Re2OCellREDM
ManufacturerL&C BioHans Biomed
ParticleVaries by line (a finer line exists separately)Approximately 75 μm
Typically used forCheeks, forehead — larger areasPeriorbital and other thin, reactive skin
In commonBoth are hADM, and both are distributed in Korea as human tissue

How this differs from the other classes

Comparison charts tend to list product names. The distinction that matters is simpler: does the product ask the skin to do the work, or does it supply the material?

By class
HA fillerCollagen stimulator
(GOURI, DCLASSY)
PN
(Rejuran)
hADM
(CellREDM, Re2O)
MechanismOccupies spaceForeign-body responseConditions environmentSupplies matrix directly
Primary targetVolume, contourLaxity, firmnessTexture, fine linesDermal density, texture
OnsetImmediateWeeks to monthsWeeksWeeks
Adds volumeYesPartiallyNoNo

Who it suits, and who it does not

Reasonable candidates

  • Thin periorbital skin where fine lines and density are the main concern
  • Patients who found that other boosters left visible injection points or a lumpy feel
  • Skin that feels thin and structurally weak overall
  • Skin made reactive by repeated laser or energy-based treatment
  • Patients who want to avoid the nodule risk of stimulator-class products

Where CellREDM alone will not get you there

  • Hollowing of the cheeks or temples — hADM creates no volume
  • A softening jawline — lifting devices or collagen stimulators
  • Deep dynamic lines — botulinum toxin or filler
  • Pregnancy or breastfeeding, or active infection at the treatment site
  • Discomfort with a human-derived material — an entirely reasonable position, and one we can plan around completely

How good is the evidence

Worth setting out plainly.

Acellular dermal matrix as a material has a long record in burn and breast reconstruction, and the principle that removing cells and antigens lowers immune-rejection risk is well established in biomaterials.

However, we found no published clinical trial data specific to CellREDM as a product. Research on injectable hADM generally remains small in scale and short in follow-up. For that reason this page makes no claim about months of duration or a required number of sessions — it is better not to state as settled what has not been settled.

On the number of sessions — No standard protocol has been established by study. We set the number against your skin and your goal, review after the first treatment, and decide together on anything further. We do not sell multi-session packages up front.

What the appointment involves

The consultation begins by separating density from volume. If hADM is appropriate, site and skin thickness decide which of the two products we use. We always explain the human-derived origin before treatment; if that is not something you are comfortable with, we plan differently.

Topical anaesthetic is applied for 20–30 minutes, then the product is placed into the dermis through a fine needle at many separate points, small volumes closely spaced.

Immediately afterwards each injection point sits slightly raised — product resting in the dermis, which settles as it is absorbed.

Timeline

  1. Day 0
    Redness and raised pointsA response to the injections themselves. The face at this stage is not the result of the treatment.
  2. Day 1–3
    Mostly settledErythema and swelling generally resolve within a few days. Bruising lasts longer.
  3. Week 2–4
    First noticeable changeLess internal tightness, makeup sitting better. The register is "filled in from underneath," not "transformed."
  4. Month 2–3
    Review pointWe assess the actual change here and discuss anything further.
  5. Beyond
    ObservationLong-term durability data are limited, so maintenance is decided on what we observe rather than a fixed schedule.

Downtime and aftercare

Most patients return to normal activity the same day. Injection marks may not be fully concealable for a day or two, so allow two or three days before anything important.

  • Cleanse gently with lukewarm water on the day; do not rub the treated area
  • Avoid sauna, jjimjilbang, strenuous exercise and alcohol for the first day
  • Use sun protection diligently
  • Resume makeup when your clinician advises
Adverse effects — As with any injectable treatment, swelling, erythema, bruising, pain, transient pigmentation and allergic reaction can occur at injection sites. These generally settle within days. If symptoms persist or worsen, return to the treating clinic for assessment. Tell your clinician beforehand if you are pregnant or breastfeeding, have an active infection at the treatment site, or have autoimmune disease. The nature and severity of adverse effects vary with individual constitution and skin condition.

Common questions

It's made from human skin. Is that all right?
The raw material is donated human skin — that is accurate. What is injected is not skin, however: all cells and DNA are removed, and only the structural components remain. Immune rejection is driven by cell-surface antigens, and those are what the process eliminates, which is why materials of this class have been used for years in burn reconstruction and breast surgery. Donated tissue is screened for hepatitis B and C, HIV and syphilis, undergoes microbiological testing, and is handled under tissue-bank regulation. Even so, if the human origin is something you are uneasy about, that judgement deserves respect. Miso Clinic stocks four products that are not human-derived, and we can plan your treatment entirely around them. Please just say so.
CellREDM or Re2O — which is better?
No study has compared them directly, so there is no basis for ranking them. Both are hADM; the choice is made by site and skin thickness. Finer particles suit thin skin such as the periorbital area, while larger areas are often treated with Re2O. At consultation we will tell you which product we intend to use and why.
Could my body reject it?
Rejection occurs when the immune system recognises antigens carried on another person's cells. hADM has had those cells and antigens removed, which is why the risk is considered low. Low is not the same as absent, and no injectable treatment is entirely free of the possibility of an allergic reaction. If anything feels wrong, come back and let us look.
Can it be used around the eyes?
Periorbital skin is thin and demanding to inject. CellREDM's fine particles are formulated with areas like this in mind, but whether it is appropriate for you depends on your skin thickness and condition, which we assess directly. For some sites a different product or a different class is the better answer.
Does it hurt?
Topical anaesthetic is applied first. Placing product at many points in the dermis is not entirely without sensation, but lower injection resistance from the finer particles makes it easier than it would otherwise be. Pain thresholds vary widely; tell us during the session if you are uncomfortable.
How many sessions will I need?
No standard course has been established by study. We set the number against your skin and your goal, review after the first treatment, and decide together on anything further.
How does this differ from Rejuran?
Rejuran (PN) improves the environment in which the skin repairs itself; CellREDM (hADM) supplies the structural material directly. If the skin is thin and reactive and the repair environment needs attention, Rejuran comes first; if density and texture have broken down and material needs replacing, CellREDM does. Where both apply we sequence them. See our Rejuran reference and the six-product comparison.
What does it cost?
It depends on volume, treatment area and whether other treatments are combined. Korean medical advertising rules govern how treatment fees may be published, so we do not list them here; we will give you exact figures at consultation.

About the authoring clinic

This reference was written and reviewed by Dr. Lee Chi-Hak, director of Miso Clinic in Daegu, South Korea. The clinic stocks six collagen boosters and skin boosters with genuinely different active materials — liquid PCL (GOURI), PN (Rejuran), hADM (Re2O, CellREDM) and CaHA (Radiesse, DCLASSY) — and selects between them according to which kind of ageing the face is actually showing. A clinic holding one product will use that product. See our comparison of all six and the references on liquid PCL, polynucleotide, hADM, DCLASSY and Radiesse.

Miso Clinic
DirectorDr. Lee Chi-Hak
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station
Telephone+82 53-428-2700
KakaoTalkMiso Clinic channel
HoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Websiteclinicmiso.co.kr
Reference libraryMiso Clinic clinical reference library — all six
한국어셀르디엠 진료 자료 (Korean)

References

  1. Acellular Dermal Matrix in Reconstructive Surgery: Applications, Benefits, and Cost, Applied Sciences. Composition, decellularisation processing, and established surgical applications.
  2. CellREDM product information (Hans Biomed). Manufacturer-published composition and particle specification.
  3. Comparison of Injectable and Sheet-Type Human Acellular Dermal Matrix, Aesthetic Plastic Surgery (2023). Tissue response comparison in an animal model.
  4. Miso Clinic protocol — formulation selection, injection depth by site, informed-consent procedure.

This page provides general information about an aesthetic treatment and does not substitute for medical diagnosis or care. Outcomes and adverse effects vary with individual skin condition, age and underlying illness, and no result is guaranteed. Decisions about treatment should be made in an in-person consultation with a qualified clinician.

← Miso Clinic home